ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.04
0.60%
US Tech 100
17,446.00
2.17%
S&P 500
5,127.79
1.26%
US Dollar vs CAD
1.36798
0.08%
Bitcoin
63,665.07
-0.36%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Moleculin Biotech Inc (MBRX)

  7. Moleculin Biotech Inc (MBRX) News

MBRX

Moleculin Biotech (MBRX)

Moleculin Biotech Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MBRX
DateTimeSourceHeadlineSymbolCompany
05/02/20248:00AMPR Newswire (US)Moleculin to Host Virtual AML Clinical Day Featuring Internationally Renowned Clinician, Martin S. Tallman, MD, on May 7, 2024NASDAQ:MBRXMoleculin Biotech Inc
05/01/20247:50AMPR Newswire (US)Moleculin Announces Formation of Scientific Advisory Board to Support Development of AnnamycinNASDAQ:MBRXMoleculin Biotech Inc
04/18/20247:30AMPR Newswire (US)European Medicines Agency (EMA) Grants Orphan Drug Designation for Moleculin's Treatment of Acute Myeloid Leukemia (AML)NASDAQ:MBRXMoleculin Biotech Inc
04/10/20247:30AMPR Newswire (US)Moleculin Announces Presentation of Positive Data Demonstrating High Anti-Cancer Activity of Annamycin and Non-Cardiotoxic PropertiesNASDAQ:MBRXMoleculin Biotech Inc
03/28/20249:45AMPR Newswire (US)Moleculin to Present at the MedInvest Biotech & Pharma Investor ConferenceNASDAQ:MBRXMoleculin Biotech Inc
03/27/20248:25AMPR Newswire (US)Moleculin to Participate in the Virtual Investor Lunch Break: The Moleculin OpportunityNASDAQ:MBRXMoleculin Biotech Inc
03/27/20248:05AMPR Newswire (US)Moleculin Announces U.S. Patent Issue Notification for Annamycin Targeting Unmet Need in AMLNASDAQ:MBRXMoleculin Biotech Inc
03/25/20246:30AMPR Newswire (US)Moleculin Announces Positive Interim Data in Annamycin MB-106 Phase 1B/2 AML TrialNASDAQ:MBRXMoleculin Biotech Inc
03/22/20243:05PMPR Newswire (US)Moleculin Reports Full Year 2023 Financial ResultsNASDAQ:MBRXMoleculin Biotech Inc
03/20/20246:30AMPR Newswire (US)Moleculin to Report Full Year 2023 Financial Results on March 22, 2024 and Host Conference Call and WebcastNASDAQ:MBRXMoleculin Biotech Inc
03/20/20246:15AMIH Market NewsJPMorgan boosts dividends, Chipotle unveils 50:1 stock split, and Latest NewsNASDAQ:MBRXMoleculin Biotech Inc
03/19/20243:30PMPR Newswire (US)Moleculin Announces Reverse Stock SplitNASDAQ:MBRXMoleculin Biotech Inc
03/12/20248:05AMPR Newswire (US)Moleculin to Present at the 36th Annual ROTH ConferenceNASDAQ:MBRXMoleculin Biotech Inc
02/29/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBRXMoleculin Biotech Inc
02/22/20248:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBRXMoleculin Biotech Inc
02/16/20244:19PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MBRXMoleculin Biotech Inc
02/15/20248:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBRXMoleculin Biotech Inc
02/14/20243:36PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBRXMoleculin Biotech Inc
02/14/20243:33PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBRXMoleculin Biotech Inc
02/12/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MBRXMoleculin Biotech Inc
02/02/20244:05PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:MBRXMoleculin Biotech Inc
01/24/20247:50AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBRXMoleculin Biotech Inc
01/24/20247:50AMPR Newswire (US)Moleculin Announces 2023 Year-End Annamycin Clinical Trials Preliminary Data and 2024 Expectations for Multiple Data Readouts and Transition to Pivotal Phase 2B/3NASDAQ:MBRXMoleculin Biotech Inc
01/16/20244:00PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MBRXMoleculin Biotech Inc
01/05/20244:15PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:MBRXMoleculin Biotech Inc
01/05/20244:14PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBRXMoleculin Biotech Inc
12/27/20236:31AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MBRXMoleculin Biotech Inc
12/22/20234:00PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:MBRXMoleculin Biotech Inc
12/21/20234:17PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBRXMoleculin Biotech Inc
12/20/20238:16PMPR Newswire (US)Moleculin Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-MarketNASDAQ:MBRXMoleculin Biotech Inc
 Showing the most relevant articles for your search:NASDAQ:MBRX

Your Recent History

USOTC
CYDY
CytoDyn (QB)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
SPZI
Spooz (PK)
USOTC
CGAC
Code Green Apparel (PK)
COIN
SHIBUSD
SHIBA INU
NASDAQ
COOP
Mr Cooper
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
TGLO
TheGlobe com (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
CNNA
Cann American (CE)
NASDAQ
LWLG
Lightwave Logic
USOTC
RNVA
Rennova Health (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
NASDAQ
AMRN
Amarin
NASDAQ
AVXL
Anavex Life Sciences
NASDAQ
DJT
Trump Media and Technology
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved